Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L Moek, Danique Giesen, Iris C Kok, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 21, 2023
Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression
Cristy R C Verzijl, Ivo P van de Peppel, Roos E Eilers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction
Jan J Koornstra, Mathilde Jalving, Fleur E M Rijcken, et al.
Elife
|
May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Arkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, et al.
Journal for Immunotherapy of Cancer
|
March 28, 2025
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment
Wellington Candido, Annemarie Cecile Eggen, Mathilde Jalving, et al.
JACC. Advances
|
November 25, 2024
Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective Study
Pieter F van den Berg, Valentina Bracun, Michel Noordman, et al.
Cancers
|
March 25, 2022
Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer
Chris J de Witte, Joachim Kutzera, Arne van Hoeck, et al.
The Lancet Regional Health. Europe
|
October 29, 2025
Longitudinal data on advanced cutaneous squamous cell carcinoma from the Dutch Keratinocyte Cancer Collaborative (DKCC): a nationwide real-world database study
Loes M Hollestein, Celeste J Eggermont, Marieke W J Louwman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2021
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
Pim P van de Donk, Thijs T Wind, Jahlisa S Hooiveld-Noeken, et al.
Oncoimmunology
|
February 7, 2019
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
Thijs T Wind, Mathilde Jalving, Jacco J de Haan, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L Moek, Danique Giesen, Iris C Kok, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 21, 2023
Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression
Cristy R C Verzijl, Ivo P van de Peppel, Roos E Eilers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction
Jan J Koornstra, Mathilde Jalving, Fleur E M Rijcken, et al.
Elife
|
May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Arkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, et al.
Journal for Immunotherapy of Cancer
|
March 28, 2025
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment
Wellington Candido, Annemarie Cecile Eggen, Mathilde Jalving, et al.
JACC. Advances
|
November 25, 2024
Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective Study
Pieter F van den Berg, Valentina Bracun, Michel Noordman, et al.
Cancers
|
March 25, 2022
Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer
Chris J de Witte, Joachim Kutzera, Arne van Hoeck, et al.
The Lancet Regional Health. Europe
|
October 29, 2025
Longitudinal data on advanced cutaneous squamous cell carcinoma from the Dutch Keratinocyte Cancer Collaborative (DKCC): a nationwide real-world database study
Loes M Hollestein, Celeste J Eggermont, Marieke W J Louwman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2021
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
Pim P van de Donk, Thijs T Wind, Jahlisa S Hooiveld-Noeken, et al.
Oncoimmunology
|
February 7, 2019
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
Thijs T Wind, Mathilde Jalving, Jacco J de Haan, et al.
Page
of 8